
Liquidity, historical trends, and peer comparisons.
According to Prothena Corporation plc’s latest financial reports and current stock price. The company's current Current Ratio is 25.05. This represents a change of 101.16% compared to the average of 12.45 of the last 4 quarters.
The mean historical Current Ratio of Prothena Corporation plc over the last ten years is 14.36. The current 25.05 Current Ratio has changed 74.48% with respect to the historical average. Over the past ten years (40 quarters), PRTA's Current Ratio was at its highest in in the December 2018 quarter at 28.90. The Current Ratio was at its lowest in in the June 2025 quarter at 5.68.
Average
14.36
Median
11.49
Minimum
7.72
Maximum
28.90
Discovering the peaks and valleys of Prothena Corporation plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 153.35%
Maximum Annual Current Ratio = 28.90
Minimum Annual Increase = -45.79%
Minimum Annual Current Ratio = 7.72
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 7.72 | -22.89% |
| 2024 | 10.01 | -10.93% |
| 2023 | 11.24 | -21.64% |
| 2022 | 14.34 | -17.97% |
| 2021 | 17.48 | 50.99% |
| 2020 | 11.58 | -45.79% |
| 2019 | 21.36 | -26.09% |
| 2018 | 28.90 | 153.35% |
| 2017 | 11.41 | 19.73% |
| 2016 | 9.53 | -43.91% |
The current Current Ratio of Prothena Corporation plc (PRTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
9.65
5-year avg
12.16
10-year avg
14.36
Prothena Corporation plc’s Current Ratio is greater than AC Immune S.A. (0.93), greater than ProMIS Neurosciences, Inc. (7.85), greater than Denali Therapeutics Inc. (8.37), greater than Annexon, Inc. (5.53), greater than Cognition Therapeutics, Inc. (7.03), greater than Neumora Therapeutics, Inc. Common Stock (4.50), greater than Acumen Pharmaceuticals, Inc. (1.89), greater than Biogen Inc. (1.95), greater than Anavex Life Sciences Corp. (15.62),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.93 | $207.11M | |
| 7.85 | $26.63M | |
| 8.37 | $2.94B | |
| 5.53 | $643.88M | |
| 7.03 | $69.41M | |
| 4.50 | $80.51M | |
| 1.89 | $18.15M | |
| 1.95 | $36.82B | |
| 15.62 | $108.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prothena Corporation plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Prothena Corporation plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Prothena Corporation plc's Current Ratio?
How is the Current Ratio calculated for Prothena Corporation plc (PRTA)?
What is the highest Current Ratio for Prothena Corporation plc (PRTA)?
What is the 3-year average Current Ratio for Prothena Corporation plc (PRTA)?
What is the 5-year average Current Ratio for Prothena Corporation plc (PRTA)?
How does the current Current Ratio for Prothena Corporation plc (PRTA) compare to its historical average?